TA802078
antibody from OriGene
Targeting: TP63
EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA802078 - Provider product page
- Provider
- OriGene
- Proper citation
- OriGene Cat#TA802078, RRID:AB_2626201
- Product name
- TP63 mouse monoclonal antibody, clone OTI4E7 (formerly 4E7)
- Antibody type
- Monoclonal
- Description
- TP63 mouse monoclonal antibody, clone OTI4E7 (formerly 4E7)
- Host
- Mouse
- Conjugate
- Unconjugated
- Epitope
- TP63
- Isotype
- IgG
- Antibody clone number
- OTI4E7
- Vial size
- 100 µl
- Concentration
- 1 mg/ml
Submitted references Primary urinary bladder adenosquamous carcinoma complicated with lower limb deep venous thromboses: a case report.
Zhang XL, Wei KL, Dang YW, Xie Y, Zhong TF, Ma Y, Chen G
International journal of clinical and experimental pathology 2014;7(12):9032-7
International journal of clinical and experimental pathology 2014;7(12):9032-7
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TP63 (RC208013, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-TP63.
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Immunohistochemical staining of paraffin-embedded Carcinoma of Human lung tissue using anti-TP63 mouse monoclonal antibody. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH9.0, 120C for 3min, TA802078)
- Validation comment
- IHC
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Figure from citation: Immunohistochemistry of TP63 protein level by using anti-TP63 antibody in the urinary bladder adenosquamous carcinoma. Dilution: 1:100
- Validation comment
- IHC